US stock market news - NYSE, NASDAQ on 23.06.2017

 

● American Airlines against deal with Qatar Airways. Just a few weeks after, how US President Donald Trump accused Qatar of terrorist financing, Qatar's flagship airline makes a surprise offer to acquire a large stake in American Airlines, Bloomberg reports. Qatar Airways Ltd. interested in acquiring about 10% American Airlines in the amount $808 million, US company says in a statement.
● Major US banks successfully passed new stress test. Investors await news next week on payments of key industry players to shareholders, reports CNBC. Test results, published Thursday by the Federal Reserve (FED), Show, what 34 systemically important US banks have sufficient capital, to withstand the two scenarios presented by the regulator, one of which is related to the financial crisis, and the other – with a lesser decline.


● The video card market will grow by 20% due to cryptocurrencies. The global video card market will end the current quarter with tangible growth due to the growing interest in cryptocurrencies, reported by Pacific Crest Securities. The mining of bitcoin and other digital currencies using graphics accelerators has caused a sharp increase in demand, что вылилось в дефицит видеокарт в нескольких регионах.
● Tesla is thinking about producing electric vehicles in China for the local market. This would allow it to avoid high import duties.

Energy stocks from the S index&P 500 fell in price by 15% year to date. The fall in their quotes in the first half of the year may become the strongest since 1990 G. This is very different from the situation in 2016 G., when they went up by 23,7%
● Irish bank AIB attracted 3 billion euros during the IPO and is estimated at 12 billion euros. AIB was one of those banks, due to the collapse of which Ireland needed international financial assistance
● Mexican regulator prepares to sue Heineken over its tequila-flavored Desperados beer brand. He claims, that the company is not allowed to use the word tequila, because this is a protected name
● AVEO Pharmaceuticals Inc share price. (NASDAQ: AVEO) grows on 62 % at premarket on friday after, как лекарственный препарат компании был рекомендован для одобрения в Европе.
● D.R. Horton Inc. (NYSE: goat) announced an increase in its offer to buy Forestar (NYSE: FOR). D.R. Horton has made an offer to purchase 75% Forestar shares for $17,75 cash per share, but not $16,25, как предполагалось ранее.
● Synchronoss Technologies Inc share price. (NASDAQ: SNCR) jumped on Friday premarket on 33% after that, as became known, that interest in its acquisition was expressed by the private investment company Siris Capital Group.
● Blackberry Ltd. (NASDAQ: BBRY) reported receiving in the first quarter in the amount of $671 million ($1,23 per share) compared to the loss in $670 million ($1,28 per share) a year earlier.
● Medtronic PLC (NYSE: MDT) stated on friday, which will increase the amount of quarterly dividends by 7% to 46 cents per share from 43 cents per share.
● Cable company Altice USA (NYSE: ATUS) debuted on Thursday in the market as a public company. Its placement was the second largest IPO of the year (after Snap) and the largest in the US telecom sector with 2000 G.

Way down
Earnings / guidance response:

  • BBBY -10.5%, AMSWA -7.3%, BBRY -4.2%, SONC -2.4%, FINL -2.4%
  HELP........

Other news

  • shock -11.6% (names Antony Mattessich to succeed Dr. Amar Sawhney as CEO on or before September 30 )
  • WKHS -8.9% (entered into at the market issuance sales agreement with Cowen to offer common stock having an aggregate offering price of up to $25,000,000)
  • BLUE -5.8% (presents interim data from the ongoing Northstar-2 (HGB-207) Phase 3 clinical study of LentiGlobin)
  • CLSN -4.2% (following late surge higher after canceling its registered direct offering of common stock announced Monday, June 19)
  • THE BRIDGE -2.5% (BBBY sympathy)
  • WSM -1% (BBBY sympathy)

Analyst Comments:

  • HAIN -3% (downgraded to Neutral from Overweight at JP Morgan)
  • LEJU -2% (downgraded to Underweight from Neutral at JP Morgan)
  • Ultrasound -1.5% (initiated with a Underperform at Credit Suisse)
  • SKT -1.4% (downgraded to Underperform from Neutral at BofA/Merrill)
  • MELI -1.2% (downgraded to Neutral from Buy at Citigroup)
  • CAT -1.1% (downgraded to Hold from Buy at Deutsche Bank)

Up
Earnings / guidance response:

  • SGH +2.1%, SNX +0.5%

Select financial names showing strength following stress tests:

  • DFS +2.4%, RF +1.5%, BAC +0.9%, WFC +0.8%, C +0.7%, JPM +0.6%, GS +0.6%, .

Other news

  • AVEO +60.3% (Eusa Pharma received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use recommending marketing authorisation of FOTIVDA (tivozanib))
  • SNCR +34.6% (Siris Capital Group affirms 12.93% active stake, delivers letter indicating that they believe they could be in a position to acquire the Company in an all-cash acquisition at $18.00/share)
  • METHOD +10.3% (FDA has granted Breakthrough Therapy designation to I.V. CR845)
  • BDSI +7% (announces that Health Canada has issued a Notice of Compliance approving BELBUCA)
  • IDRA +6.9% ( confirmed the FDA granted orphan drug designation for IMO-2125, an agonist of endosomal Toll-like receptor 9 for the treatment of melanoma Stages IIb to IV)
  • OUR +3.3% ( to sell several non-core assets for up to $70 million; continues to actively market additional non-core assets)
  • ADHD +2.7% (conducting a process to explore and review a range of strategic alternatives)
  • CNAT +2% (granted orphan designation by the FDA for its compound for the treatment of primary sclerosing cholangitis)
  • THC +1.9% (continued strength)
  • HIMX +1.8% (increases annual dividend per ADS to $0.24/ADS from $0.12/ADS)
  • RIGL +1.4% (Rigel Pharma will present data from its FIT Phase 3 clinical program evaluating the safety and efficacy of TAVALISSE in patients with chronic or persistent immune thrombocytopenia on June 24 from 12:30 – 12:45pm (CESTF) at the European Hematology Association 22nd Annual Congress)
  • EVH +1.4% (prices secondary offering by selling shareholders of 4.5 mln shares of common stock at $25.90 per share)
  • PFE +1.3% (receives Complete Response Letter from the FDA regarding the Biologics License Application for its proposed epoetin alfa biosimilar)
  FCX : Freeport-McMoRan Copper & Gold Inc.

Analyst Comments:

  • CBAY +4.1% (initiated with a Outperform at Oppenheimer)
  • AKS +4.1% (upgraded to Buy from Hold at Deutsche Bank)
  • X +2.9% (upgraded to Buy from Hold at Deutsche Bank)
  • DBVT +2.7% (initiated with a Buy at Deutsche Bank)
  • RH +2.2% (upgraded to Buy from Hold at Deutsche Bank )
  • VRTX +1.3% (upgraded to Buy from Hold at Needham)
  • GILD +1% (initiated with a Buy at Deutsche Bank)
  • BIIB +0.9% (initiated with a Buy at Deutsche Bank)
  • OCLR +0.8% (initiated with a Buy at DA Davidson)
  • SBUX +0.6% (initiated with a Overweight last night after the close at KeyBanc Capital Mkts)

Stock Scanner :

52H 52L $winner UP $ loser
JNJ
VRTX
CELG
UTX
ARE
DLR
BLUE
RCL
WYN
RHT
CLVS
ABC
KITE
Q
MDT
PRXL
NVS
CNC
XLV
MDSO
XBI
LOXO
ABBV
MOH
GOOD
CCL
DFT
LUV
ATVI
BAX
TAP
TJX
SLB
TSCO
WHAT
APC
PDCE
HES
NLSN
BBBY
HAIN
DVN
TSRO
PBYI
MDSO
PVH
ORCL
NVS
PANW
GILD
CNC
KMX
ALXN
RH
CLVS
rdus
HATE
ACHC
HCA
VNTV
EVHC
TXRH
ABBV
GOOD
ARE
CM
SPLK
LLY
INCY
MOH
SON
BIB
CLVS
GOOD
INCY
CELG
VRTX
RHT
WFM
BIB
ALXN
BLUE
PBYI
ESPR
XBI
BABA
SON
BMRN
KITE
ADBE
rdus
NVS
SHOP
GILD
NOW
ORCL
TSRO
MDSO
LOXO
DWT
WGO
PRXL
BURL
ACN
WB
SINA
JDST
WLTW
DPS
AMP
CNK
BLUE
BMRN
RCL
WBA
PRU
PNC
XPO
ST
PEP
PTLA
PFG
DUST
CB
AON
BTI
DWT
BABA
HA
WHITE
EQR
OLLI

Scroll to Top